Phio Pharmaceuticals

Phio Pharmaceuticals Inc.
Company typePublic
Nasdaq: PHIO
IndustryBiotechnology
Founded2011 (2011)
HeadquartersMarlborough, Ma., United States of America
Key people
Robert Bitterman (president and CEO)
Websitewww.phiopharma.com

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.